Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dzau

Showing results (51-60 of 438) with videos related to

Pageof 44
Sort By:
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1987
Clinical response to angiotensin-converting enzyme inhibition in cardiac failureV J Dzau, M A Creager
Circulation|February 26, 2024
RNA Therapeutics for the Cardiovascular SystemVictor J Dzau, Conrad P Hodgkinson
Hypertension (Dallas, Tex. : 1979)|March 8, 2002
Physiological genomics: implications in hypertension researchSusan B Glueck, Victor J Dzau
Annals of Medicine|May 24, 2001
Gene therapy for human bypass graftsA A Mangi, V J Dzau
Science (New York, N.Y.)|May 3, 1996
Molecular therapies for vascular diseasesG H Gibbons, V J Dzau
Annual Review of Medicine|January 1, 1997
Nitric oxide synthase: role in the genesis of vascular diseaseJ P Cooke, V J Dzau
Life Sciences|February 15, 1982
Hormonal control of angiotensinogen productionV J Dzau, H C Herrmann
Journal of Cardiovascular Pharmacology|January 1, 1993
Vascular remodeling: mechanisms and implicationsV J Dzau, G H Gibbons
Cardiovascular Drugs and Therapy|February 1, 1990
Angiotensin converting enzyme inhibition and vascular hypertrophy in hypertensionG H Gibbons, V J Dzau
Annals of Internal Medicine|January 15, 1990
The time has come for vascular medicineJ P Cooke, V J Dzau
Pageof 44

Showing results (51-60 of 438) with videos related to

Sort By:
Pageof 44
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1987
Clinical response to angiotensin-converting enzyme inhibition in cardiac failureV J Dzau, M A Creager
Circulation|February 26, 2024
RNA Therapeutics for the Cardiovascular SystemVictor J Dzau, Conrad P Hodgkinson
Hypertension (Dallas, Tex. : 1979)|March 8, 2002
Physiological genomics: implications in hypertension researchSusan B Glueck, Victor J Dzau
Annals of Medicine|May 24, 2001
Gene therapy for human bypass graftsA A Mangi, V J Dzau
Science (New York, N.Y.)|May 3, 1996
Molecular therapies for vascular diseasesG H Gibbons, V J Dzau
Annual Review of Medicine|January 1, 1997
Nitric oxide synthase: role in the genesis of vascular diseaseJ P Cooke, V J Dzau
Life Sciences|February 15, 1982
Hormonal control of angiotensinogen productionV J Dzau, H C Herrmann
Journal of Cardiovascular Pharmacology|January 1, 1993
Vascular remodeling: mechanisms and implicationsV J Dzau, G H Gibbons
Cardiovascular Drugs and Therapy|February 1, 1990
Angiotensin converting enzyme inhibition and vascular hypertrophy in hypertensionG H Gibbons, V J Dzau
Annals of Internal Medicine|January 15, 1990
The time has come for vascular medicineJ P Cooke, V J Dzau
Pageof 44